Universitätsklinikum Würzburg

New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study (2019) Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkharde H, Eby N, Flacke JP, et al. Journal article Actual Treatment Options for Giant Cell Arteritis (2019) Moosig F, Schmalzing M, Aries PM, Henes J, Lamprecht P, Rech J, Witte T Journal article Age as a Key Factor in the Pattern, Extent and timing Process of Distant Metastasis in Patients with malignant Melanoma. A Study by the German Central Register of Malignant Melanoma (2019) Gassenmaier M, Leiter U, Eigentler T, Roecken M, Keim U, Gesierich A, Moritz R, et al. Conference contribution Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry (2019) Gassenmaier M, Keim U, Leiter U, Eigentler TK, Roecken M, Gesierich A, Moritz RKC, et al. Journal article REEPITHELIALIZATION IN FOCUS: RAPID SCREENING OF WOUND CLOSURE USING ORGANOTYPIC SKIN MODELS (2019) Kiesewetter L, Littau L, Boccaccini AR, Walles H, Groeber-Becker F Conference contribution Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (2019) Saraceni F, Labopin M, Brecht A, Kroeger N, Eder M, Tischer J, Labussiere-Wallet H, et al. Journal article Invasive fungal infection - New treatments to meet new challenges Invasive Pilzinfektionen (2019) Von Lilienfeld-Toal M, Wagener J, Einsele H, Cornely OA, Kurzai O Journal article, Review article Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials (2019) Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, et al. Journal article Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark (2019) Brinker TJ, Hekler A, Hauschild A, Berking C, Schilling B, Enk AH, Haferkamp S, et al. Journal article A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article